Form 4: RCM Technologies Executive Sells Shares

Michael Saks, Division President at RCM Technologies, Inc., reported a sale of 1,208 shares of common stock on May 4, 2026, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Michael Saks, Division President, Healthcare Services at RCM Technologies, Inc., sold 1,208 shares of common stock.
• The transaction occurred on May 4, 2026.
• The sale was executed under a Rule 10b5-1 trading plan, established on December 6, 2024, intended to comply with affirmative defense conditions.
• The sale price was $32.50 per share.
• Following the transaction, Mr. Saks beneficially owns 89,267 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was conducted under a pre-established Rule 10b5-1 plan, indicating a planned divestiture rather than a reaction to company performance.

Negatives

• An executive sold a portion of their holdings in the company.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider sales, particularly under Rule 10b5-1 plans, are common for executives managing their personal finances and diversifying holdings. The key is the pre-arranged nature of the plan, which is designed to avoid accusations of trading on material non-public information.

Stakeholder Impact

• Shareholders may view insider sales with caution, though the Rule 10b5-1 plan mitigates concerns about insider knowledge.

Key Dates

Keywords

RCM Technologies, Form 4, Insider Trading, Stock Sale, Rule 10b5-1, Michael Saks, Beneficial Ownership